| Jack Geoula, M,D | |
|
2700 Dolbeer St, St Joseph Hospital - Eureka, Eureka, CA 95501-4736 | |
| (707) 845-8121 | |
| Not Available |
| Full Name | Jack Geoula |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 29 Years |
| Location | 2700 Dolbeer St, Eureka, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821006263 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A94898 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Martin Luther King, Jr. Community Hospital | Los angeles, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Superior Hospitalist Medical Group Inc | 1456650928 | 63 |
News Archive
Throughout the pandemic, infectious disease experts and frontline medical workers have asked for a faster, cheaper and more reliable COVID-19 test.
Individuals who suffer from migraines with aura (temporary visual or sensory disturbances before or during a migraine headache) are at a higher risk of dying from heart disease or stroke.
A team of scientists from Italy and Brazil has recently conducted a training program for sniffer dogs to detect coronavirus disease 2019 (COVID-19). They have trained the dogs to accurately sense COVID-19 specific volatile organic compounds in sweat samples collected from COVID-19 patients. The study is currently available on the medRxiv* preprint server.
Emergent BioSolutions Inc. reported total revenue for Q1 2014 of $53.9 million as compared to $43.1 million in 2013. In addition, Q1 2014 net loss was $20.2 million, or $0.55 per share, as compared to a net loss of $8.1 million, or $0.22 per share, in 2013.
› Verified 4 days ago
| Entity Name | Superior Hospitalist Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780047712 PECOS PAC ID: 1456650928 Enrollment ID: O20160504002343 |
News Archive
Throughout the pandemic, infectious disease experts and frontline medical workers have asked for a faster, cheaper and more reliable COVID-19 test.
Individuals who suffer from migraines with aura (temporary visual or sensory disturbances before or during a migraine headache) are at a higher risk of dying from heart disease or stroke.
A team of scientists from Italy and Brazil has recently conducted a training program for sniffer dogs to detect coronavirus disease 2019 (COVID-19). They have trained the dogs to accurately sense COVID-19 specific volatile organic compounds in sweat samples collected from COVID-19 patients. The study is currently available on the medRxiv* preprint server.
Emergent BioSolutions Inc. reported total revenue for Q1 2014 of $53.9 million as compared to $43.1 million in 2013. In addition, Q1 2014 net loss was $20.2 million, or $0.55 per share, as compared to a net loss of $8.1 million, or $0.22 per share, in 2013.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jack Geoula, M,D 8300 Wyoming Blvd Ne, Albuquerque, NM 87113-1997 Ph: () - | Jack Geoula, M,D 2700 Dolbeer St, St Joseph Hospital - Eureka, Eureka, CA 95501-4736 Ph: (707) 845-8121 |
News Archive
Throughout the pandemic, infectious disease experts and frontline medical workers have asked for a faster, cheaper and more reliable COVID-19 test.
Individuals who suffer from migraines with aura (temporary visual or sensory disturbances before or during a migraine headache) are at a higher risk of dying from heart disease or stroke.
A team of scientists from Italy and Brazil has recently conducted a training program for sniffer dogs to detect coronavirus disease 2019 (COVID-19). They have trained the dogs to accurately sense COVID-19 specific volatile organic compounds in sweat samples collected from COVID-19 patients. The study is currently available on the medRxiv* preprint server.
Emergent BioSolutions Inc. reported total revenue for Q1 2014 of $53.9 million as compared to $43.1 million in 2013. In addition, Q1 2014 net loss was $20.2 million, or $0.55 per share, as compared to a net loss of $8.1 million, or $0.22 per share, in 2013.
› Verified 4 days ago
Eric Gerdes, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Dolbeer St, Eureka, CA 95501 Phone: 707-269-4250 | |
Paul Windham, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1915 Harrison Ave Ste A, Eureka, CA 95501 Phone: 707-497-6342 Fax: 707-497-6234 | |
Marcelle Mahan, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Dolbeer St, Eureka, CA 95501 Phone: 707-269-4250 | |
Joseph B. Burkes, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 714 F St, Eureka, CA 95501 Phone: 707-442-5335 Fax: 707-442-1452 | |
Dr. Deonnae Lopez, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2700 Dolbeer St, Eureka, CA 95501 Phone: 707-269-4250 | |
Alan Morden, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2700 Dolbeer St, Eureka, CA 95501 Phone: 707-445-8121 Fax: 707-269-3753 | |
Tuan Luu, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Dolbeer St, Eureka, CA 95501 Phone: 707-269-4250 |